Option delistings effective August 18th include Q32 Bio Inc (QTTB), Hyperdynamics Corp (HYPD), Bionano Genomics (BNGO), Allurion Technologies Inc (ALUR), Moxian (BVI) Inc (ABTS), Spi Energy Co Ltd (SPIEF), TVARDI THERAPEUTICS INC (TVRD), and ZK International Group Ltd (ZKIN).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QTTB:
- Q32 Bio Inc. Advances Alopecia Areata Treatment with Phase 2a Trial of Bempikibart
- Q32 Bio Inc. Reports Continued Losses Amid Development Efforts
- Q32 Bio Appoints New Interim Chief Medical Officer
- Q32 Bio chief medical officer Jason Campagna to depart
- Oxford Biomedica completes acquisition of remaining stake in U.S. subsidiary